4.7 Article

Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy

期刊

PEDIATRICS
卷 147, 期 5, 页码 -

出版社

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2020-042507

关键词

-

资金

  1. ICES - Ontario Ministry of Health and Long-Term Care
  2. Canadian Institutes of Health Research [PJT-159519, MY7-161351]
  3. Department of Family and Community Medicine, University of Toronto
  4. BC Children's Hospital Foundation
  5. Canadian Child Health Clinician Scientist Program
  6. Michael Smith Foundation for Health Research

向作者/读者索取更多资源

The study found that maternal immunization with Tdap vaccine during pregnancy did not increase the risk of adverse health outcomes in early childhood. In fact, inverse associations were observed with upper respiratory infections, gastrointestinal infections, and urgent and inpatient health service use.
BACKGROUND AND OBJECTIVES: Maternal immunization with tetanus, diphtheria, and acellular pertussis vaccine (Tdap) is routinely recommended in many countries as a strategy to protect young infants against severe pertussis infection; few studies have assessed whether prenatal exposure to the vaccine is associated with any longer-term adverse health effects in children. We evaluated the long-term safety of exposure to Tdap vaccination during pregnancy. METHODS: Population-based retrospective cohort study conducted in Ontario, Canada using multiple linked province-wide health administrative databases. All live births between April 2012 and March 2017 were included, and children were followed for up to 6 years to ascertain study outcomes. Children exposed to prenatal Tdap were propensity score matched to unexposed children at a 1:5 ratio. Tdap vaccination during pregnancy was ascertained by using vaccine-specific fee codes. Immune-related (infectious diseases, asthma) and nonimmune-related (neoplasm, sensory disorders) outcomes and a nonspecific morbidity outcome (urgent or inpatient health service use) were evaluated from birth to end of follow-up. RESULTS: Of 625 643 live births, 12 045 (1.9%) were exposed to Tdap in utero. There were no significant increased risks of adverse childhood outcomes and prenatal Tdap exposure; however, we observed inverse associations (adjusted incidence rate ratio [95% confidence interval]) with upper respiratory infections (0.94 [0.90-0.99]), gastrointestinal infections (0.85 [0.79-0.91]), and urgent and inpatient health service use (0.93 [0.91-0.96]). CONCLUSIONS: Exposure to Tdap vaccination in pregnancy was not associated with any increased risk of adverse health outcomes in early childhood, supporting the long-term safety of Tdap administration in pregnancy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据